Your browser doesn't support javascript.
loading
Comparative effectiveness of cefmetazole versus carbapenems and piperacillin/tazobactam as initial therapy for bacteremic acute cholangitis: A retrospective study.
Aoto, Kazuhiro; Inose, Ryo; Kosaka, Tadashi; Shikata, Keisuke; Muraki, Yuichi.
Afiliação
  • Aoto K; Department of Pharmacy, University Hospital, Kyoto Prefectural University of Medicine, Kajii-Cho, Kawaramachi-Hirokoji, Kamigyo-Ku, Kyoto, 602-8566, Japan; Laboratory of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, 5 Misasaginakauchicho, Kyoto Yamashina-ku, Kyoto, 607-8414, Japan.
  • Inose R; Laboratory of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, 5 Misasaginakauchicho, Kyoto Yamashina-ku, Kyoto, 607-8414, Japan. Electronic address: inose2019@mb.kyoto-phu.ac.jp.
  • Kosaka T; Department of Pharmacy, University Hospital, Kyoto Prefectural University of Medicine, Kajii-Cho, Kawaramachi-Hirokoji, Kamigyo-Ku, Kyoto, 602-8566, Japan. Electronic address: tkosaka@koto.kpu-m.ac.jp.
  • Shikata K; Department of Pharmacy, University Hospital, Kyoto Prefectural University of Medicine, Kajii-Cho, Kawaramachi-Hirokoji, Kamigyo-Ku, Kyoto, 602-8566, Japan. Electronic address: kshikata@koto.kpu-m.ac.jp.
  • Muraki Y; Laboratory of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, 5 Misasaginakauchicho, Kyoto Yamashina-ku, Kyoto, 607-8414, Japan. Electronic address: y-muraki@mb.kyoto-phu.ac.jp.
J Infect Chemother ; 30(3): 213-218, 2024 Mar.
Article em En | MEDLINE | ID: mdl-37832824

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Cefmetazol / Bacteriemia Limite: Humans Idioma: En Revista: J Infect Chemother Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Cefmetazol / Bacteriemia Limite: Humans Idioma: En Revista: J Infect Chemother Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão